TECX Q2 2021 Earnings — Tectonic Therapeutic, Inc. Revenue & Financial Results | Market Cap Arena

TECXTectonic Therapeutic, Inc.

$635M

Q2 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$299,000

Operating Income

-$31M

Net Income

-$31M

EPS (Diluted)

$-8.84

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$20M

Free Cash Flow

-$21M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$238M

Total Liabilities

$17M

Stockholders' Equity

$221M

Cash & Equivalents

$226M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$299,000	-$301,000	+0.7%
Operating Income	-$31M	-$29M	-8.7%
Net Income	-$31M	-$29M	-8.9%